期刊文献+

2002-2011年鲍曼不动杆菌临床分布及耐药性变迁分析 被引量:9

Analysis of Clinical Distribution and Transition of Drug Resistance of Acinetobacter Baumannii in the Year of 2002-2011
下载PDF
导出
摘要 目的:探讨昆明市第一人民医院2002年1月-2011年12月临床分离鲍曼不动杆菌的临床分布、耐药性及变迁情况,指导临床合理用药。方法:采用Microscan Walkaway 40SI鉴定系统辅以传统手工方法鉴定细菌。采用K-B纸片琼脂扩散法进行体外药物敏感性试验,通过Whonet 5.6软件进行耐药性数据分析。结果:2002-2011年鲍曼不动杆菌高发于重症监护室(0~54株),神经外科(4~50株),呼吸科(3~37株),消化科在2003年集中检出45株。检出标本包括痰液(86.2%),肺泡灌洗液(1.5%),血液(1.1%)。2002-2011年所检测的24种抗菌药物耐药率表现为氨苄西林、头孢唑林、头孢西丁10年来持续100%,庆大霉素为52.9%~62.9%,丁胺卡那为12.1%~62.5%,妥布霉素为16.7%~75%,氨苄西林-舒巴坦为0%~61.4%,头孢哌酮-舒巴坦为0%~50%,阿莫西林-克拉维酸为0%~66.9%,哌拉西林-他唑巴坦为33.3%~75%,替卡西林-克拉维酸为14.3%~75%,环丙沙星为42.9%~66.8%,氧氟沙星为57.1%~100%,左氧氟沙星为22.7%~82.4%,哌拉西林为37.5%~75%,头孢哌酮为36.6%~80.8%,头孢曲松为52%~74.1%,头孢他啶为38.2%~75%,头孢吡肟为38.5%~75%,氨曲南为0%~87.5%,亚胺培南为0%~58.8%,美罗培南为0%~12.5%,复方新诺明为20.9%~27.1%,米诺环素为0%~25%。结论:鲍曼不动杆菌分离数量逐年上升,易检出于患者呼吸不畅的科室,抗菌药物耐药严重且呈大幅度上升,并渐显多重耐药特性。 Objective: To investigate the clinical distribution , drug resistance and transition of Acinetobacter ba-mannii isolated by the first people hospital of Kunmming city from Jan . 2002 to Dec . 2011 , so as to provide a ref-erence for rational drug use in clinical practice . Methods: MicroScan WalkAway 40SI and conventional bacterial i-dentification assays were adopted for bacterial identification . The drug susceptibility test was conducted by K-B disc method and Whonet 5 . 6 software was used for the data analysis . Results: During 2002 - 2011 Acinetobacter bau-mannii was mostly detected in those departments such as ICU ( 0 ~ 54 strains ) , neurosurgery ( 4 ~ 50 strains ) and respiratory departments ( 3 ~ 37 strains ) . About 45 isolates was detected in digestion department in 2003 . The most numbers of isolates were found from sputum ( 86 . 2%) , balf ( 1 . 5%) and blood ( 1 . 1%) . The drug re-sistant rates of 24 kinds of antibiotics were observed including AMP 100%,CZO 100%,FOX 100%, GEN 52.9% ~62.9%,AMK 12.1% ~ 62.5%,TOB 16.7% ~ 75%,SAM 0% ~ 61.4%,CSL 0% ~ 50%,AMC 0% ~ 66.9%, TZP 33 . 3% ~ 75%, TCC 14 . 3% ~ 75%, CIP 42 . 9% ~ 66 . 8%, OFX 57 . 1% ~ 100%, LVX 22 . 7% ~ 82 . 4%, PIP 37.5% ~ 75%,CFP 36.6% ~ 80.8%,CRO 52% ~ 74.1%,CAZ 38.2% ~ 75%,FEP 38.5% ~ 75%,ATM 0% ~87 . 5%, IMP 0% ~ 58 . 8%, MEM 0% ~ 12 . 5%, SXT 20 . 9% ~ 27 . 1% and MNO 0% ~ 25%. Conclusion: The isolated numbers of Acinetobacter baumannii increased year by year and most were found in the areas where there were patients with shortness of breath . Antimicrobial drug resistance was serious and with an increasing trend , and the characteristics of multidrug resistance was found .
出处 《中国执业药师》 CAS 2015年第1期8-12,共5页 China Licensed Pharmacist
基金 卫生部公益性行业科研基金(201002021)
关键词 鲍曼不动杆菌 抗菌药物 耐药率 耐药变迁 Acinetobacter Bamannii Antibacterial Drug Resistance Transition of Drug Resistance
  • 相关文献

参考文献13

二级参考文献75

  • 1邓健康,郭晓兰,黄义山.我院凝固酶阴性葡萄球菌感染临床分析[J].中国感染控制杂志,2006,5(1):58-61. 被引量:11
  • 2潘晓龙,周东升,吴祥林,方平.从携带多种耐药基因认识鲍曼不动杆菌多重耐药性[J].江西医学检验,2006,24(1):3-6. 被引量:12
  • 3王辉,郭萍,孙宏莉,杨启文,陈民钧,朱元珏,徐英春,谢秀丽.碳青霉烯类耐药的不动杆菌分子流行病学及其泛耐药的分子机制[J].中华检验医学杂志,2006,29(12):1066-1073. 被引量:237
  • 4许宏涛,陶凤蓉,梁玉珍,王国新,邹艳玲,胡云建,张秀珍.铜绿假单胞菌对喹诺酮类药物耐药机制的研究[J].中国感染与化疗杂志,2007,7(2):92-95. 被引量:14
  • 5Peleg AY, Seifert H, Paterson DL. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev, 2008, 21(3): 538-582.
  • 6Adams-Haduch JM, Paterson DL, Sidjabat HE, et al. Genetic basis of multidrug resistance in Acinetobacter baumannii clinical isolates at a tertiary medical center in Pennsylvania. Antimicreb Agents Chemother , 2008, 52( 1 ) : 3837-3843.
  • 7Fu Y, Zhou J, Zhou H, et al. Wide dissemination of OXA-23- producing carbapenem-resistant Acinetobacter baumannii clonat complex 22 in multiple cities of China. J Antimicrob Chemother, 2010, 65(4) : 644-650.
  • 8Wang H, Guo P, Sun H, et al. Molecular epidemiology of clinical isolates of carbapenem-resistant Acinetobacter spp. from Chinese hospitals. Antimicrob Agents Chemother, 2007, 51 ( 11 ) : 4022-4028.
  • 9Yu YS, Zhou H, Yang Q, et al. Widespread occurrence of aminoglycoside resistance due to ArmA methylase in imipenem-resistant Acinetobacter baumannii isolates in China. J Antimicrob Chemoth- er, 2007, 60(2) : 454-455.
  • 10Magnet S,Courvalin P,Lambert T.Resistance-nodulation-cell division-type efflux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454[J].Antimicrob Agents Chemother,2001,45(12):3375-80.

共引文献101

同被引文献72

  • 1王爽,李冬,范霞,邱淑文,陈佰义.革兰阳性球菌耐药性监测研究[J].中国公共卫生,2004,20(7):825-826. 被引量:4
  • 2朱德妹,汪复,吴培澄,刘陈谊,朱悦心.临床常见致病菌的耐药性监测[J].中国抗生素杂志,1989,14(6):415-419. 被引量:16
  • 3赵坤,刘兴友,李培庆,王三虎,李军民,刘丽艳,梁美兰.中药制剂对仔猪大肠杆菌性腹泻的治疗效果[J].安徽农业科学,2006,34(11):2408-2409. 被引量:20
  • 4汪复.2005中国CHINET细菌耐药性监测结果[J].中国感染与化疗杂志,2006,6(5):289-295. 被引量:284
  • 5Hayakawa K, Gattu S, Marchaim D, et al. Epidemiology and risk factors for isolation of Escherichia coil producing CTX-M-type extended-spectrum β-1actamase in a large U.S.Medieal Center [J].Antimicrob Agents chemother, 2013,57 ( 8 ) : 4010-4018.
  • 6Wyllie D,Paul J,Crook D.Waves of trouble:MRSA stranamics and assessment of the impact of infection control[J].J antimicrob Chemother,2011,66(12):2685-2688.
  • 7CANTON R. Antibiotics resistance genes from the environment: a perspective through newly identified antibiotic resistance mechanisms in the clinical setting[J]. Clinical Microbiology and infection,2009,15(sl):20-25.
  • 8MARTINEZ J L. Natural antibiotic resistance and contamination by antibiotic resistance determinants: the two ages in the evolution of resistance to antimicrobials[J]. Frontiers in Microbiology, 2012(3): 1-3.
  • 9MARTINEZ J L, BAQUERO F. Emergence and spread of antibiotic resistance: setting a parameter space[J]. Upsala Journal of Medical Sciences, 2014,119(2):68-77.
  • 10BAQUERO F, ALVAREZ-ORTEGA C, MARTINEZ J L. Ecology and evolution of antibiotic resistance[J]. Environmental Microbiology Reports,2009, 16 (1):469-476.

引证文献9

二级引证文献39

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部